An attempt at the first global malaria vaccine began in Malawi as part of a large-scale pilot project implemented by the World Health Organization (WHO) to partially protect the disease.
360,000 children should take vaccines for injection within one year after the introduction of a pilot in Ghana and Kenya where injected children aged 5 to 17 months.
The World Health Organization (WHO) has said that the Ministries of Health in those countries decide where the vaccines will be used.
RTS, S, which in the course of clinical trials prevented about four out of ten malaria cases, enabled the immune system to attack the malaria parasite spread by mosquito bites, the WHO says.
"We need new solutions to get a response to malaria on the right path, and this vaccine gives us a promising tool to achieve this goal. The Malaria vaccine can save 10,000 children, "said the Director General of the World Health Organization dr. Tedros Adhan Ghebreyesus.
In 2018, when the pilot program was announced, the World Health Organization said that Ghana, Malawi and Kenya were selected as a pilot program because they continued to record large numbers of cases of malaria despite extensive, well-run anti-malaria programs.
The vaccine is given four times: once a month for three months and then the fourth dose 18 months later.
Also known as Mosquirix, the vaccine was created by scientists at the British pharmaceutical giant GSK in 1987. It has been run by years of testing and has been supported by many organizations, including PATH, a non-profit organization.
The pilot is financed by Gavi; vaccination alliance; Global Fund to Fight Aids, Tuberculosis and Malaria; Unitaid; WHO; and GSK.
Worldwide efforts to combat malaria have led to a 62% reduction in deaths between 2000 and 2015, but the disease still affects more than 200 million people, with almost half a million, mostly children, having died.
The World Health Organization said that the vaccine will be used in addition to insecticides and mosquito nets, which are currently two main methods of prevention with limited impact.
Other measures to curb malaria have also been adopted, with the latest in September 2018, when the Burkina Faso government announced that it had given the green light to the release of genetically modified mosquitoes in the village of Burkinabe Bana.
The program was part of target malaria, led by the Bill Foundation and Melinda Gates. It has also been an effort to use bioengineering to eradicate the spread of malaria by reducing the number of insects that spread the disease.
It is expected that about 10,000 mosquitoes will come into the atmosphere, mostly men. They are sterile and if they happen to bite, they will not release any genetically manipulated material, reports Scientific research.